Cargando…

Immune Cell Networks Uncover Candidate Biomarkers of Melanoma Immunotherapy Response

The therapeutic activation of antitumour immunity by immune checkpoint inhibitors (ICIs) is a significant advance in cancer medicine, not least due to the prospect of long-term remission. However, many patients are unresponsive to ICI therapy and may experience serious side effects; companion biomar...

Descripción completa

Detalles Bibliográficos
Autores principales: Vo, Duong H. T., McGleave, Gerard, Overton, Ian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225330/
https://www.ncbi.nlm.nih.gov/pubmed/35743743
http://dx.doi.org/10.3390/jpm12060958

Ejemplares similares